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Study objective: To investigate the impact of an ovarian dermoid cyst or dermoid cyst surgery on ovarian
reserve in patients undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI).
Design: We performed a retrospective cohort study by using the records of patients with a history of
ovarian dermoid cyst who underwent IVF/ICSI between 2009 and 2013. The antral follicle count (AFC)
obtained by transvaginal ultrasound during controlled ovarian hyperstimulation of IVF/ICSI, total number
of basal follicles [i.e., basal antral follicle count (B-AFC)], and dominant follicles greater than 1.4 cm [i.e.,
dominant antral follicle count (D-AFC)] were calculated between the different groups.
Patients: We included 260 patients with a history of dermoid cyst excision and 23 patients with a
dermoid cyst who underwent IVF/ICSI. Two hundred and eighty-three matched patients without a
dermoid cyst and ovarian surgery history were included.
Intervention: None.
Measurements and main results: The B-AFC was signiﬁcantly smaller in the dermoid cyst group than in
the matched control group (p ¼ 0.030). The B-AFC and D-AFC were both signiﬁcantly smaller for the
previously operated ovary than for the contralateral nonoperated ovary (p ¼ < 0.001), and both were
smaller in the ovary with a teratoma than in the other teratoma-free ovary with a mean reduction of
40.5% and 38.8%, respectively (p ¼ 0.018 and p ¼ 0.004, respectively). The B-AFC and D-AFC were
signiﬁcantly fewer in ovaries treated by open surgery than in ovaries treated laparoscopically (p ¼ 0.031
and p ¼ 0.028, respectively). There was no signiﬁcant difference in the main IVF outcomes between the
two groups or the subgroups.
Conclusion: Our results suggest that ovarian dermoid cyst excision could signiﬁcantly reduce ovarian
reserve to a similar extent as the cyst itself. The presence or resection of dermoid cysts will not affect the
main IVF outcomes.
Copyright © 2016, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).interest to declare relevant to
edicine, Shandong Provincial




A mature ovarian cystic teratoma, also called a dermoid cyst, is
the most common ovarian tumor in women of reproductive age
and constitutes up to 20% of all ovarian tumors.1 Despite its high
prevalence, studies are scarce concerning its effect on ovarian
reserve and its treatment strategy in infertile patients, although
one previous study showed an increased prevalence of infertility
among women with mature cystic teratomas.2y InvasiveTherapy. PublishedbyElsevierTaiwanLLC. This isanopenaccessarticleunder theCC
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raises the following questions: (1) does surgical treatment of a
dermoid cyst impact the ovarian reserve? (2) does a dermoid cyst
and its resection impair the prognosis of assisted reproductive
technologies (ARTs)? and (3) does the cyst damage the surrounding
ovarian tissue? Until recently, deﬁnitive data have rarely been
available to clarify these issues. Few studies have speciﬁcally
investigated residual ovarian function after laparoscopic excision of
dermoid cysts, especially in association with infertility. Kim et al3
reported no difference in the serum levels of anti-Müllerian hor-
mone (AMH) between women with mature cystic teratomas and
age-matched and body mass index (BMI)-matched controls. They
speculated that mature cystic teratomas do not signiﬁcantly affect
ovarian reserve, whereas stage IV endometriomas may be closely
associated with decreased ovarian reserve. The effects of surgical
treatment are often more harmful to the ovarian reserve, compared
to the cyst itself. Surgical treatment of the dermoid cyst seems to
affect the antral follicle count (AFC). Urman et al4 reported that the
AFC decreased more than 10% 6 months after cystectomy for
endometriomas, compared to the preoperative count. Somigliana
et al5 declared that the laparoscopic excision of nonendometrioid
benign ovarian cysts, which included only seven cases of dermoid
cyst, was associated with signiﬁcant injury to the ovarian reserve.
Purpose/Aim
The aim of the present study was to evaluate the impact of
excising an ovarian dermoid cyst on ovarian reserve and the
response to ovarian stimulation.
Materials and methods
We performed a retrospective cohort study that involved the
collection of data from the electronic records of women who un-
derwent in vitro fertilization/intracytoplasmic sperm injection
(IVF/ICSI) between January 2009 and December 2013 in the Center
for Reproductive Medicine at Shandong Provincial Hospital Afﬁli-
ated to Shandong University (Jinan, China). Patients were moni-
tored and managed in accordance with standardized clinical
protocols used at the hospital. We initially included 304 patients
who were previously diagnosed with a dermoid cyst by post-
operative pathologic examination or by transvaginal ultrasound
scan (TVS). Twenty-one patients were excluded because they met
the following exclusion criteria: (1) dermoid cyst recurrence after
surgery, (2) history of adnexectomy, or (3) previous ovarian surgery.
If an included patient underwent several oocyte retrieval cycles,
only the ﬁrst cycle was included. Two hundred and sixty patients
who had a history of dermoid cyst resection and 23 patients who
had a dermoid cyst but no resection were ﬁnally included in Group
1. The control group (Group 2), which comprised women without
ﬁbroids, was matched to the study group by the following criteria:
(1) age (± 1 year), (2) number of cycles, (3) type of infertility (i.e.,
primary or secondary), (4) presence of tubal disease (as diagnosed
by a history of ectopic pregnancy or tubal obstruction) or history of
tubal surgery, (5) history of surgery for endometrial polyps, (6)
presence of male factors (oligospermia, asthenospermia, azoo-
spermia), (7) presence of polycystic ovary syndrome,(8) type of
protocol used for controlled ovarian hyperstimulation (COH), and
(9) presence of endometriosis or adenomyosis. We required exact
matching for criteria 1e3. For criteria 4e9, we attempted to match
individuals as closely as possible. For most individuals, we were
able to match at least three of these criteria. Researchers
performing the matching were blinded to the IVF/ICSI outcomes. If
multiple patients matched the criteria, one patient was chosen at
random. All patients underwent routine COH. Day 3 AFCs beforestarting ovarian stimulation (i.e., the B-AFC) and the number of
dominate follicles (D-AFC) that were greater than 1.4 cm at the time
of human chorionic gonadotropin (hCG) administration were
calculated. Detailed TVS monitoring before and during IVF/ICSI
cycles was systematically applied and recorded; it had compara-
bility with ultrasound assessment.
To avoid a large difference in number when comparing women
who had surgery and women who did not have surgery (260
women vs. 23 women), we only included patients who had lapa-
roscopic cystectomy into Group 1.1 and included patients who had
no surgical management on the ovary into Group 1.2. This
comparison was more acceptable because the ratio of the case
numbers was lowered to 108:23, and the evaluation of open
surgery for just the removal of an ovarian cyst was less meaningful.
In both subgroups, the total number of B-AFC and D-AFC in each
ovary was compared. The pregnancy outcomes such as cancella-
tion, clinical miscarriage, clinical pregnancy rate (CPR), and delivery
rate (DR) were compared.
Moreover, in the unilateral surgery subgroup, the difference in
the AFC numbers between women who underwent an open sur-
gery approach and laparoscopic approach was also measured. In
our paper,△1 ¼ (AFC on the nonsurgery side of the ovary) e (AFC
on the surgery side of the ovary).△2 ¼ (AFC on the teratoma-free
side of the ovary) e (AFC on the teratoma side of the ovary). To
clarify whether the impact is related to the surgical procedure and/
or to a prior cyst, we compared the values between△1 and△2. A
schematic diagram of our study is shown in Figure S1.
Statistical analysis was performed using SPSS version 17.0 (SPSS
Inc., Chicago, IL, USA) while taking into consideration the match
between each case woman and her control. Normally distributed
datawere presented as themean and standard deviation. Abnormal
distribution data were presented as the median (interquartile
range). For continuous variables, the difference between the mean
of the patients and the mean of the controls was computed and
tested using a t test for paired comparisons. For proportions, the
Chi-square test or Fisher's exact test were applied. The Krus-
kaleWallis nonparametric test, followed by the ManneWhitney U
test, was applied for non-normal distributive data. A two-tailed
p < 0.05 was considered signiﬁcant.
This study was approved by the Institutional Review Board of
Shandong University (Jinan, China). Written informed consent was
obtained from the participants at the time of their presentation for
IVF/ICSI treatment.
Results
Two hundred eighty-three patients fulﬁlled the inclusion
criteria and were paired with 283 matched controls (Figure 1). The
characteristics of the patients and the ovarian stimulation out-
comes are shown in Table 1. Group 1 comprised patients who had
undergone ovarian dermoid cyst resection unilaterally (n ¼ 203) or
bilaterally (n ¼ 57) and 23 patients who still had a dermoid cyst
during IVF/ICSI. Group 2 included 283 matched controls without a
dermoid cyst or cystectomy. The oocyte retrieval procedure was
successful without complications. There was no report of teratoma
torsion or peritonitis during or after oocyte retrieval. No torsionwas
reported during the pregnancies. Table 1 shows no signiﬁcant
differences in most of the items compared. However, the mean
B-AFC (in the left and right ovaries) was signiﬁcantly smaller in
Group 1 than in Group 2 (13.9 ± 7.1 vs. 15.9 ± 8.1; p ¼ 0.030). The
median number of good quality embryos transferred was signiﬁ-
cantly higher in Group 2 than in Group 1 (2 embryos vs. 1 embryo;
p ¼ 0.029). There were no differences between the two groups in
the main IVF outcomes such as the CPR and DR (Table 2). The
clinical miscarriage rate was slightly higher in Group 1 than in
Figure 1. A schematic of the database searching pathway and the group divisions. ICSI ¼ intracytoplasmic sperm injection; IVF ¼ in vitro fertilization.
Table 1
The baseline characteristics of the patients and the in vitro fertilization outcomes of Groups 1 and 2.
Item Group 1 Group 2 p
Patients (n) 283 283
Age (y) 30.9 ± 4.6 30.8 ± 4.5 NS
Body mass index (kg/m2) 23.4 ± 3.7 23.1 ± 3.4 NS
Day 3 serum FSH (IU/mL) 7.2 ± 2.8 6.9 ± 2.5 NS
Day 3 serum E2 (pg/mL) 43.9 ± 33.1 41.4 ± 33.1 NS
B-AFC (left þ right ovary) 13.9 ± 7.1 15.9 ± 8.1 0.030
Starting dose of Gn 190 ± 48 183 ± 45 NS
Total dosage of Gn per cycle (IU) 2210 ± 975 2068 ± 779 NS
Mean number of oocytes retrieved 11.8 ± 6.9 12.6 ± 6.6 NS
Good quality embryo transferred (ManneWhitney U test) a 1 (0, 2) 2 (0, 2) 0.029
Mean number of embryos transferred 1.5 ± 0.5 1.5 ± 0.5 NS
B-AFC ¼ basal antral follicle count; D-AFC ¼ dominant antral follicle count; E2 ¼ estradiol; FSH ¼ follicle stimulating hormone; Gn ¼ gonadotropin; Group 1 ¼ patients who
had a dermoid cyst þ prior surgery; Group 2 ¼ patients who had dermoid cyst þ no prior surgery; IFV ¼ in vitro fertilization; NS ¼ not signiﬁcant.
a Themean number of good quality embryos transferred is 1.0 in Group 1 (i.e., dermoid cystþ prior surgery). Themean number of good quality embryos transferred is 1.1 in
Group 2 (i.e., dermoid cyst þ no prior surgery).
Table 2
The IVF/ICSI outcomes in Group 1 and Group 2.
Item Group 1 Group 2 p OR
Cancellation rate 37/283 (13.1) 39/283 (13.7) 0.805 0.94 (0.58e1.53)
Clinical miscarriage rate 29/159 (18.2) 17/140 (12.1) 0.088 1.75 (0.92e3.33)
CPR per started cycle 159/283 (56.2) 141/283 (49.8) 0.130 1.31 (0.93e1.80)
DR per started cycle 109/283 (38.5) 102/283 (35.7) 0.356 0.66 (0.27e1.62)
Data are presented as the n/N (%), unless otherwise indicated.
CPR ¼ clinical pregnancy rate; DR ¼ delivery rate; Group 1 ¼ patients who had a dermoid cyst þ prior surgery; Group 2 ¼ patients who had dermoid cyst þ no prior surgery;
ICSI ¼ intracytoplasmic sperm injection; IVF ¼ in vitro fertilization; OR ¼ odds ratio.
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mean size of a dermoid cyst in Group 1.2 was 2.2 ± 1.3 cm.We could
not present the size of the dermoid cysts before surgery in Group
1.1.
Table 3 shows the comparison of the AFC between the bilateral
ovaries. The characteristics of patients and the ovarian stimulation
outcomes are shown in Table 1. In Group 1.1, the mean B-AFC was8.4 ± 4.2 follicles in the control ovary and 5.8 ± 4.3 follicles in the
previously operated ovary (p ¼ < 0.001). The D-AFC was 6.0 ± 3.5
follicles in the control ovary and 3.8 ± 3.3 follicles in the previously
operated ovary (p ¼ < 0.001). This decrease in the B-AFC corre-
sponded to a mean reduction of 31% (95% conﬁdence interval,
24.5e37.5%) and the decrease in the D-AFC corresponded to a mean
reduction of 35% (95% conﬁdence interval, 24.5e45.7%). The B-AFC
Table 3
The antral follicle count comparison between the bilateral sides of the ovaries.
Item B-AFC D-AFC
One side (203 patients in Group 1.1)
Surgery side 5.8 ± 4.3 3.8 ± 3.3
Nonsurgery side 8.4 ± 4.2 6.0 ± 3.5
p < 0.001 < 0.001
Nonsurgery (23 patients in Group 1.2)
Teratoma side 5.3 ± 3.8 3.7 ± 2.3
Nonteratoma side 8.9 ± 6.2 6.0 ± 4.1
p 0.018 0.004
Surgery type
Open surgery side of the ovary (116 patients) 5.2 ± 4.5 3.3 ± 3.0
Laparoscopy side of the ovary (87 patients) 6.5 ± 3.8 4.4 ± 3.6
p 0.031 0.028
Surgery & teratoma
△1 a 3.61 ± 6.78 2.35 ± 3.52
△2 b 2.60 ± 3.92 2.18 ± 3.95
p 0.489 0.843
B-AFC ¼ basal antral follicle count; D-AFC ¼ dominant antral follicle count.
a △1 ¼ (AFC on the nonsurgery side of the ovary) e (AFC on the surgery side of
the ovary).
b △2 ¼ (AFC on the teratoma-free side of the ovary) e (AFC on the teratoma side
of the ovary).
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cantly less than that of the ovary subjected to laparoscopic surgery
(87 patients; p ¼ 0.031), although no signiﬁcant difference existed
between the nonoperated sides in the two groups (p ¼ 0.262). In
Group 1.2, the B-AFC and D-AFC in the ovary with a teratoma were
both signiﬁcantly lower than in the other teratoma-free ovary
(p ¼ 0.018 and p ¼ 0.004, respectively) with a mean reduction of
40.5% (95% conﬁdence interval, 7.6e73.7%) and 38.8% (95% conﬁ-
dence interval, 13.6e64.1%), respectively.
However, the decrease in the B-AFC and D-AFC in the previously
operated ovary is a combined effect of the impact of surgery and the
dermoid cyst itself (Figure S1). Therefore, a comparison of△1 and
△2 could, to some extent, show the real effect of surgery on
ovarian reserve. This result showed that the decrease in the B-AFC
and D-AFC caused by dermoid cyst resection or the dermoid cyst
itself did not reach signiﬁcance (p ¼ 0.489 and p ¼ 0.843, respec-
tively). This ﬁnding may indicate that dermoid cyst resection does
not impact ovarian reserve, as evaluated by AFC.
To explain the aforementioned results, we re-evaluated the
pathologic results of the thin cortex above dermoid cyst from
several patients. We found ﬁbrosis and a loss of cortex-speciﬁc
stroma in the stretched cortex. We also collected the ultrasound
results of several women in our clinics. We found that the AFC of
the deromoid cyst side was lower than that of the tumor-free side
(Figure S2). Table S2 shows no differences between Group 1.1 and
Group 1.2 in the main IVF outcomes such as CPR and DR.
Discussion
Several studies6,7 have advocated a relationship between
endometriosis, infertility, and reduced ovarian reserve. Ovarian
response may be reduced in some women who have undergone
surgery for endometriomas. However, few studies have evaluated
dermoid cysts with regard to the aforementioned issues. In this
study, we demonstrated that surgical excision of an ovarian
dermoid cyst signiﬁcantly decreases the AFC, compared to the AFC
of the nonoperated side. Moreover, an existing teratoma could also
signiﬁcantly reduce the AFC and ovarian function, based on the
analysis of Group 1.2. Therefore, a dermoid cyst itself or its surgical
resection could also lower the ovarian reserve, similar to an
endometrioma. There were no signiﬁcant differences in the main
IVF outcomes between the dermoid cyst group (i.e., Group 1) andthe matched control group (i.e., Group 2), or between the surgery
subgroup (i.e., Group 1.1) and nonsurgery subgroup (i.e., Group 1.2).
Our results indicated that teratoma resection may not signiﬁcantly
impact the main IVF outcomes.
In Group 1, the presence of an ovarian dermoid cyst was
conﬁrmed ultrasonographically. We excluded patients with recur-
rent dermoid cysts, a history of adnexectomy, and previous
surgeries on the other ovary because these surgeries could have
inﬂuenced the AFC comparison and added confounding factors to
our results.
The mean B-AFC in Group 1 was signiﬁcantly smaller than in
Group 2, which could prove that surgery had a harmful effect to
some extent on ovarian reserve. Our ﬁnding indicated that, like
endometriosis, a dermoid cyst itself could reduce ovarian reserves.
Kitajima et al8 evaluated the histologic features of ovarian cortical
tissue in endometriomas and found signiﬁcantly lower follicular
density, compared to the cortical tissue of the contralateral normal
ovary. They also found ﬁbrosis and a loss of cortex-speciﬁc stroma
in endometrioma tissues. Our study also had similar results. We
preliminarily demonstrated an association between tissue alter-
ations in the dermoid cyst and reduced ovarian reserve. We spec-
ulated that the mechanical stretching of the enlarged ovary cortex
induced by the dermoid cyst could also cause ﬁbrosis and loss of
follicles. This factor may explain our results of signiﬁcant AFC
reduction in ovaries with a dermoid cyst, compared to the tumor-
free ovary; however, this phenomenon needs further detailed
pathological investigation.
The mean size of the dermoid cyst in Group 1.2 was very small.
The accuracy of the AFCmeasurement in the presence of an ovarian
cyst is questionable, although a small size may increase the accu-
racy. For example, based on Figures S2C and S2D, we could clearly
distinguish between the tumor and the AFCs. Our data showed that
damage to the ovary reserve was related to the surgical procedure
and to the dermoid cyst. Almog et al9 compared AFCs in ovaries
harboring different types of cysts with the contralateral normal
ovaries and found that a dermoid cyst does not inﬂuence the AFC.
Our study showed that a laparoscopic approach was preferable
to open surgery in protecting ovarian function. One study10 of 55
patients who underwent laparoscopic surgery for dermoid cysts,
which measured 2e15 cm, found residual ovarian parenchyma
6e12 months later, even when no parenchyma was visible before
surgery. The proportion of open surgery was high and was possibly
related to the lagging deployment of laparoscopic surgery in China.
However, the laparoscopic technique is increasingly becoming
widespread. Surgical management by laparoscopic cystectomy
could help to prevent potential complications such as rupture,
torsion, or malignancy during IVF/ICSI and later pregnancy.
Surgeons should protect ovarian function carefully by retaining
as much ovarian tissue as possible. There are many reports7,11 that
state that hemostasis by bipolar coagulation after stripping an
endometrioma reduces ovarian reserve to a greater extent than
suturing, as determined by serial AMH levels. Therefore, suturing
may be a better hemostatic choice after stripping out an ovarian
endometriomas. In our study, we did not have detailed information
on whether electrocoagulation or suturing was used. However, we
believe that the same consideration with regard to endometriomas
should apply to dermoid cyst excision. Thermal and mechanical
injury to the ovary should be avoided. Physicians should keep in
mind that any operation on the ovary compromises ovarian func-
tion. Potential deleterious mechanisms are the accidental removal
of any ovarian tissue during cystectomy, damage inﬂicted on the
ovarian stroma, and vascularization by surgery-related local
inﬂammation and electrosurgical coagulation during hemostasis.5
The evidence from our study is inconclusive concerning
whether dermoid cysts should be removed in infertile women
L. Yan et al. / Gynecology and Minimally Invasive Therapy 5 (2016) 161e165 165planning IVF. Caspi et al12 reported the results of ovarian stimula-
tion and IVF in the presence of dermoid cysts and found no effects
related to the presence of a cyst or the parameters of stimulation or
IVF, based on the data of only six patients with dermoid cysts. A
systematic review13 recently showed that surgery for endome-
trioma does not signiﬁcantly affect ovarian reserve, as evaluated by
AFC. In our study, we demonstrated no signiﬁcant differences in the
ovarian stimulation parameters and main IVF/ICSI outcomes
between the two groups, whereas surgical resection does harm the
ovarian reserve. Complications such as cyst torsion, infection,
hemostasis, or malignant transformation can arise inwomenwith a
dermoid cyst undergoing ART; therefore, laparoscopic ovarian
cystectomy sometimes may ﬁrst be recommended for women,
especially when the dermoid cyst is large and the ovarian reserve is
good. However, if a small dermoid cyst (usually < 5 cm) is discov-
ered just before IVF with no symptoms or signs of malignancy, we
believe that the correct choice is to continue with IVF and continue
monitoring the cyst, especially if the ovarian reserve is not good.
Our study has the following strengths. First, the 260 patients
studied were the largest reported sample. Second, the matching
procedures were a very important strength of this study. The
control group (i.e., Group 2) was speciﬁcally chosen to eliminate
confounding variables. As far as we know, few previous studies
were as strictly and systematically controlled for age, number of
cycles, comorbidities, and other confounding factors as our study
was. Third, this study had awithin-patient comparison of the ovary
undergoing unilateral surgery with the unoperated ovary. We
compared the bilateral sides of the ovarian follicles to eliminate
individual bias. Fourth, we found that the main IVF outcomes may
not be impacted by whether the teratoma is resected. We specu-
lated that mature cystic teratomas could cause simple mechanical
tissue stretching and signiﬁcantly affect ovarian reserve. There is no
current consensus on the management of dermoid cyst before ART;
therefore, our study may help in this issue.
Some limitations of our research should be noted. This was a
retrospective study and therefore it may have a selection bias. Data
were collected from one IVF center, but there was no control in the
manner in which the surgeries were performed. Most of our
included patients had their surgery in other hospitals; therefore,
we do not know how much normal ovary was removed in each
patient. We also could not present clearly the surgical techniques.
We do not knowwhether the difference in ovarian reservewas only
because of the surgery or because of the history or the presence of a
dermoid cyst. It is possible that there was a difference before the
surgery. We only analyzed the cross-sectional data of the AFC.
There was no prestimulation follow up of ovarian function. We did
not use AMH because we used within-patient comparisons and
because AMH, which more accurately evaluates ovarian function,
represents the whole bilateral ovarian function. We did not stan-
dardize the timing of the ovarian reserve measurements relative to
the surgery. It would not have made a difference for the control-
versus-case study (because it was the same person), although a
well-designed randomized controlled trial on this aspect is needed
to generate the best evidence while overcoming the pitfalls of
observational studies.
Our study showed that, after a teratoma resection, the AFC is
signiﬁcantly lower on the operated side than on the nonoperated
side. Surgical excision of an ovarian dermoid cyst may signiﬁcantlydecrease ovarian function to a similar extent as the cyst itself; thus,
its adverse effect on ovarian reserve is not a core issue. Whether a
teratoma is resected may not impact the main IVF outcomes. In
view of the aforementioned facts, laparoscopic ovarian cystectomy
may sometimes be recommended ﬁrst for women, especially when
the dermoid cyst is large and the ovarian reserve is good. However,
for most patients with a dermoid cyst presenting for ART, ovarian
surgery should be avoided if there are no proper indications such as
malignant transformation, especially when the ovarian reserve is
poor.
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